Tonix Pharmaceuticals (NASDAQ:TNXP) Research Coverage Started at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “sell” rating on the stock. Separately, Dawson James initiated coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a “buy” rating […]
More Stories
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Significant Increase in Short Interest
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a large increase in short interest in the...
Rakuten Group, Inc. (OTCMKTS:RKUNY) Sees Significant Growth in Short Interest
Rakuten Group, Inc. (OTCMKTS:RKUNY – Get Free Report) was the recipient of a large growth in short interest in September....
StoneCo Ltd. (NASDAQ:STNE) Short Interest Update
StoneCo Ltd. (NASDAQ:STNE – Get Free Report) saw a large increase in short interest in the month of September. As...
Telesis Bio, Inc. (NASDAQ:TBIO) Sees Significant Growth in Short Interest
Telesis Bio, Inc. (NASDAQ:TBIO – Get Free Report) was the target of a significant increase in short interest during the...
New Research by Candace Owens Casts Doubt on Kamala Harris’s Heritage Claims
By Stephen Zogopoulos, USNN World News In a recent wave of investigative efforts led by Candace Owens, Vice President Kamala...
Kensington Hedged Premium Income ETF (KHPI) to Issue Dividend of $0.19 on October 1st
Kensington Hedged Premium Income ETF (NYSEARCA:KHPI – Get Free Report) announced a dividend on Friday, September 27th, NASDAQ reports. Stockholders...